| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5841345 | Life Sciences | 2016 | 17 Pages |
Abstract
The reduction in infarct size is a major finding. The LLLT cardioprotection may be mediated by several molecular and cellular mechanisms. Although these results are exciting, there are many limitations that must be resolved before LLLT clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fernando Pereira Carlos, Vanessa Gradinetti, Martha Manchini, Paulo de Tarso Camillo de Carvalho, José Antonio Jr., Adriana Castello Costa Girardi, Ernesto Cesar Pinto Leal-Junior, Danilo Sales Bocalini, Stella Vieira, Ednei Luiz Antonio, Paulo Tucci,